HEDIS® Results
Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
65.12% |
64.90% |
68.04% |
66.15% |
Annual Dental Visits (ADV) Total |
NB |
54.60% |
|
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
46.35% |
46.74% |
46.71% |
48.16% |
Appropriate Testing for Pharyngitis (CWP) |
75.10% |
77.56% |
83.89% |
85.11% |
Appropriate Treatment for Upper Respiratory Infection (URI) Total |
95.88% |
93.08% |
94.52% |
91.27% |
Asthma Medication Ratio (AMR) Total |
78.47% |
69.41% |
74.60% |
70.56% |
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
73.01% |
66.19% |
70.21% |
67.03% |
Blood Pressure Control (<140/90) for Patients With Diabetes (BPD) |
72.26% |
68.61% |
71.05% |
71.78% |
Breast Cancer Screening (BCS) |
48.71% |
55.25% |
|
|
Breast Cancer Screening (BCS-E) |
48.57% |
54.94% |
48.83% |
56.66% |
Cervical Cancer Screening (CCS) |
59.12% |
59.85% |
53.77% |
60.10% |
Childhood Immunization Status (CIS) Combination #10 |
32.60% |
35.04% |
29.44% |
31.32% |
Chlamydia Screening in Women (CHL) Total |
50.48% |
61.07% |
51.01% |
61.46% |
Controlling High Blood Pressure (CBP) |
61.31% |
65.45% |
60.83% |
67.40% |
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
78.84% |
80.86% |
81.00% |
83.51% |
Eye Exam for Patients With Diabetes (EED) |
50.61% |
56.20% |
46.96% |
57.09% |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
33.01% |
27.73% |
27.92% |
27.62% |
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
51.41% |
46.35% |
52.12% |
44.33% |
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
39.34% |
41.03% |
39.75% |
42.86% |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
37.26% |
37.31% |
43.32% |
37.64% |
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
55.69% |
57.90% |
52.41% |
56.86% |
Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase |
|
|
52.41% |
56.83% |
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
53.77% |
55.72% |
53.77% |
59.64% |
Immunizations for Adolescents (IMA) Combination #2 |
30.66% |
38.93% |
32.60% |
38.69% |
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
16.07% |
16.94% |
16.05% |
16.78% |
Kidney Health Evaluation for Patients with Diabetes (KED) |
41.49% |
38.80% |
41.95% |
42.10% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total |
28.52% |
39.01% |
28.70% |
41.92% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total |
|
|
28.70% |
41.41% |
Pharmacotherapy for Opioid Use Disorder (POD) Total |
13.95% |
31.93% |
12.44% |
29.01% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
77.22% |
75.79% |
75.38% |
74.78% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
87.21% |
86.96% |
84.15% |
86.54% |
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
83.14% |
≤ 92.72% |
89.81% |
≤ 91.24% |
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
90.27% |
86.86% |
88.56% |
86.89% |
Prenatal and Postpartum Care (PPC) Postpartum Care |
82.00% |
80.78% |
84.67% |
82.48% |
Prenatal Immunization Status (PRS) Combination Rate |
28.47% |
25.81% |
|
|
Prenatal Immunization Status (PRS-E) Combination Rate |
28.47% |
25.81% |
26.79% |
24.92% |
Risk of Continued Opioid Use (COU) 31-Day Total |
1.97% |
≤ 2.45% |
2.08% |
≤ 2.79% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
82.24% |
81.64% |
82.50% |
83.00% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
71.02% |
73.63% |
71.52% |
74.07% |
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
63.98% |
67.07% |
62.49% |
67.01% |
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
68.31% |
70.37% |
69.39% |
70.91% |
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
59.03% |
63.89% |
63.18% |
64.10% |
Use of Imaging Studies for Low Back Pain (LBP) |
73.15% |
75.44% |
70.47% |
72.74% |
Use of Opioids at High Dosage (HDO) |
4.46% |
≤ 2.19% |
4.39% |
≤ 2.14% |
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
2.24% |
≤ 0.87% |
2.22% |
≤ 1.22% |
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
76.64% |
83.21% |
73.24% |
86.20% |
NA = Not Available
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate